• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环金属化亚氨基膦烷金(III)和铂(II)配合物。一种具有良好抗癌特性的高渗透性阳离子铂(II)化合物。

Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties.

作者信息

Frik Malgorzata, Fernández-Gallardo Jacob, Gonzalo Oscar, Mangas-Sanjuan Víctor, González-Alvarez Marta, Serrano del Valle Alfonso, Hu Chunhua, González-Alvarez Isabel, Bermejo Marival, Marzo Isabel, Contel María

机构信息

†Department of Chemistry, Brooklyn College, The City University of New York, Brooklyn, New York 11210, United States.

‡Chemistry Ph.D. Program, The Graduate Center, The City University of New York, 365 Fifth Avenue, New York, New York 10016, United States.

出版信息

J Med Chem. 2015 Aug 13;58(15):5825-41. doi: 10.1021/acs.jmedchem.5b00427. Epub 2015 Jul 22.

DOI:10.1021/acs.jmedchem.5b00427
PMID:26147404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4538566/
Abstract

New organometallic gold(III) and platinum(II) complexes containing iminophosphorane ligands are described. Most of them are more cytotoxic to a number of human cancer cell lines than cisplatin. Cationic Pt(II) derivatives 4 and 5, which differ only in the anion, Hg2Cl6(2-) or PF6(-) respectively, display almost identical IC50 values in the sub-micromolar range (25-335-fold more active than cisplatin on these cell lines). The gold compounds induced mainly caspase-independent cell death, as previously reported for related cycloaurated compounds containing IM ligands. Cycloplatinated compounds 3, 4, and 5 can also activate alternative caspase-independent mechanisms of death. However, at short incubation times cell death seems to be mainly caspase dependent, suggesting that the main mechanism of cell death for these compounds is apoptosis. Mercury-free compound 5 does not interact with plasmid (pBR322) DNA or with calf thymus DNA. Permeability studies of 5 by two different assays, in vitro Caco-2 monolayers and a rat perfusion model, have revealed a high permeability profile for this compound (comparable to that of metoprolol or caffeine) and an estimated oral fraction absorbed of 100%, which potentially makes it a good candidate for oral administration.

摘要

本文描述了含有亚氨基膦烷配体的新型有机金属金(III)和铂(II)配合物。其中大多数对多种人类癌细胞系的细胞毒性比顺铂更强。阳离子铂(II)衍生物4和5仅在阴离子上有所不同,分别为Hg2Cl6(2-)或PF6(-),在亚微摩尔范围内显示出几乎相同的IC50值(在这些细胞系上比顺铂活性高25 - 335倍)。如先前报道的含IM配体的相关环金化合物一样,金化合物主要诱导不依赖半胱天冬酶的细胞死亡。环铂化合物3、4和5也能激活其他不依赖半胱天冬酶的死亡机制。然而,在短时间孵育时,细胞死亡似乎主要依赖半胱天冬酶,这表明这些化合物的主要细胞死亡机制是凋亡。无汞化合物5不与质粒(pBR322)DNA或小牛胸腺DNA相互作用。通过两种不同的测定方法,即体外Caco - 2单层细胞和大鼠灌注模型对5进行的通透性研究表明,该化合物具有高通透性特征(与美托洛尔或咖啡因相当),估计口服吸收分数为100%,这使其有可能成为口服给药的良好候选药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/7a4848b7cbe1/jm-2015-00427e_0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/f1c7ef9a6d01/jm-2015-00427e_0021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/5721399eca8e/jm-2015-00427e_0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/16141d479cf7/jm-2015-00427e_0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/b0fa894d78d5/jm-2015-00427e_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/0f658553b2f3/jm-2015-00427e_0018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/a57bc706a249/jm-2015-00427e_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/2f596bf43fc9/jm-2015-00427e_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/619d0c176575/jm-2015-00427e_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/4bc9e2188caf/jm-2015-00427e_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/790315a2ad3f/jm-2015-00427e_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/e3bec613517f/jm-2015-00427e_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/4bace114a87a/jm-2015-00427e_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/e9357b9eff1f/jm-2015-00427e_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/9b7d2f470185/jm-2015-00427e_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/97ae59871c80/jm-2015-00427e_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/0639055f7ced/jm-2015-00427e_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/d7f71c61924c/jm-2015-00427e_0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/222cd8f1f7d8/jm-2015-00427e_0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/7a4848b7cbe1/jm-2015-00427e_0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/f1c7ef9a6d01/jm-2015-00427e_0021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/5721399eca8e/jm-2015-00427e_0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/16141d479cf7/jm-2015-00427e_0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/b0fa894d78d5/jm-2015-00427e_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/0f658553b2f3/jm-2015-00427e_0018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/a57bc706a249/jm-2015-00427e_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/2f596bf43fc9/jm-2015-00427e_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/619d0c176575/jm-2015-00427e_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/4bc9e2188caf/jm-2015-00427e_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/790315a2ad3f/jm-2015-00427e_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/e3bec613517f/jm-2015-00427e_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/4bace114a87a/jm-2015-00427e_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/e9357b9eff1f/jm-2015-00427e_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/9b7d2f470185/jm-2015-00427e_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/97ae59871c80/jm-2015-00427e_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/0639055f7ced/jm-2015-00427e_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/d7f71c61924c/jm-2015-00427e_0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/222cd8f1f7d8/jm-2015-00427e_0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b03e/4538566/7a4848b7cbe1/jm-2015-00427e_0015.jpg

相似文献

1
Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties.环金属化亚氨基膦烷金(III)和铂(II)配合物。一种具有良好抗癌特性的高渗透性阳离子铂(II)化合物。
J Med Chem. 2015 Aug 13;58(15):5825-41. doi: 10.1021/acs.jmedchem.5b00427. Epub 2015 Jul 22.
2
Cytotoxic hydrophilic iminophosphorane coordination compounds of d⁸ metals. Studies of their interactions with DNA and HSA.d⁸ 金属的细胞毒性亲水性亚膦酰胺配位化合物。与 DNA 和 HSA 相互作用的研究。
J Inorg Biochem. 2012 Nov;116:204-14. doi: 10.1016/j.jinorgbio.2012.06.017. Epub 2012 Jul 6.
3
Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.抗癌环金属化[Au(III)m(C(楔)N(楔)C)mL]n+化合物:合成与细胞毒性特性
Chemistry. 2006 Jul 5;12(20):5253-66. doi: 10.1002/chem.200600117.
4
Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives.一种新型有机金属铂(II)配合物及其金(I)异双金属衍生物的细胞毒性特性
Dalton Trans. 2016 Jan 14;45(2):579-90. doi: 10.1039/c5dt02714d.
5
Cyclometalated Complexes of Platinum and Gold with Biological Properties: State-of-the-Art and Future Perspectives.具有生物活性的铂和金环金属配合物:现状与未来展望
Curr Med Chem. 2018 Feb 12;25(4):437-461. doi: 10.2174/0929867324666170529125229.
6
Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold.组氨酸-2-叶立德与咪唑-2-叶立德配体对钌、铱、铂和金配合物的抗癌和抗血管生成活性的影响
J Inorg Biochem. 2016 Oct;163:221-228. doi: 10.1016/j.jinorgbio.2016.07.021. Epub 2016 Jul 27.
7
Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells.具有强大细胞毒性的铂(II)配合物在人类癌细胞中的作用机制研究。
J Med Chem. 2009 Sep 10;52(17):5474-84. doi: 10.1021/jm9007104.
8
Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand.新型单核和双核 Pd(II)和 Pt(II)配合物的合成、表征、与 DNA 的相互作用及体外细胞毒性研究,配体为苯并[d]噻唑-2-胺。
Inorg Chem. 2011 Jun 6;50(11):4732-41. doi: 10.1021/ic102142j. Epub 2011 Apr 26.
9
Novel cis-[(NHC)(NHC)(L)Cl]platinum(ii) complexes - synthesis, structures, and anticancer activities.新型顺式 - [(N - 杂环卡宾)(N - 杂环卡宾)(配体)氯]铂(II)配合物——合成、结构及抗癌活性
Dalton Trans. 2016 Oct 21;45(39):15390-15398. doi: 10.1039/c6dt02350a. Epub 2016 Sep 6.
10
Anticancer C,N-cycloplatinated(II) complexes containing fluorinated phosphine ligands: synthesis, structural characterization, and biological activity.含氟膦配体的抗癌 C,N-环铂(II)配合物的合成、结构表征及生物活性。
Inorg Chem. 2013 Dec 2;52(23):13529-35. doi: 10.1021/ic401973k. Epub 2013 Nov 14.

引用本文的文献

1
Cyclometalated complexes: promising metallodrugs in the battle against cancer.环金属化配合物:抗癌斗争中颇具潜力的金属药物。
RSC Med Chem. 2025 Jul 31. doi: 10.1039/d5md00178a.
2
Targeting Cancer Cell Fate: Apoptosis, Autophagy, and Gold Nanoparticles in Treatment Strategies.靶向癌细胞命运:治疗策略中的细胞凋亡、自噬与金纳米颗粒
Curr Issues Mol Biol. 2025 Jun 14;47(6):460. doi: 10.3390/cimb47060460.
3
Efficient and Sustainable Electrosynthesis of -Sulfonyl Iminophosphoranes by the Dehydrogenative P-N Coupling Reaction.通过脱氢P-N偶联反应高效可持续地电合成磺酰基亚氨基膦烷

本文引用的文献

1
Luminescent iminophosphorane gold, palladium and platinum complexes as potential anticancer agents.发光亚氨基磷烷金、钯和铂配合物作为潜在的抗癌剂。
Inorg Chem Front. 2014;1(3):231-241. doi: 10.1039/C4QI00003J. Epub 2014 Mar 7.
2
Stabilization of G-quadruplex DNA, inhibition of telomerase activity, and tumor cell apoptosis by organoplatinum(II) complexes with oxoisoaporphine.含氧化异阿朴啡的有机铂(II)配合物对G-四链体DNA的稳定作用、端粒酶活性的抑制及肿瘤细胞凋亡
J Med Chem. 2015 Mar 12;58(5):2159-79. doi: 10.1021/jm5012484. Epub 2015 Feb 18.
3
Dual antitumor and antiangiogenic activity of organoplatinum(II) complexes.
JACS Au. 2024 Apr 18;4(6):2188-2196. doi: 10.1021/jacsau.4c00156. eCollection 2024 Jun 24.
4
Research Progress of Metal Anticancer Drugs.金属抗癌药物的研究进展
Pharmaceutics. 2023 Dec 11;15(12):2750. doi: 10.3390/pharmaceutics15122750.
5
A Conformationally Restricted Gold(III) Complex Elicits Antiproliferative Activity in Cancer Cells.一种构象受限的金(III)配合物可在癌细胞中发挥抗增殖活性。
Inorg Chem. 2023 Aug 14;62(32):13118-13129. doi: 10.1021/acs.inorgchem.3c02066. Epub 2023 Aug 2.
6
Platinum(IV)-Gold(I) Agents with Promising Anticancer Activity: Selected Studies in 2D and 3D Triple-Negative Breast Cancer Models.具有显著抗癌活性的铂(IV)-金(I)制剂:二维和三维三阴性乳腺癌模型中的精选研究
Chemistry. 2023 Oct 23;29(59):e202302045. doi: 10.1002/chem.202302045. Epub 2023 Sep 5.
7
Cyclometallated Palladium(II) Complexes: An Approach to the First Dinuclear Bis(iminophosphorane)phosphane-[C,N,S] Metallacycle.环金属化钯(II)配合物:首例双核双(亚胺膦烷)膦烷-[C,N,S]金属环的方法。
Molecules. 2022 Oct 19;27(20):7043. doi: 10.3390/molecules27207043.
8
Synthesis of New Thiourea-Metal Complexes with Promising Anticancer Properties.具有潜在抗癌特性的新型硫脲-金属配合物的合成
Molecules. 2021 Nov 16;26(22):6891. doi: 10.3390/molecules26226891.
9
Investigation on Optical and Biological Properties of 2-(4-Dimethylaminophenyl)benzothiazole Based Cycloplatinated Complexes.基于 2-(4-二甲氨基苯基)苯并噻唑的环铂配合物的光学和生物学性质研究。
Chemistry. 2021 Nov 11;27(63):15757-15772. doi: 10.1002/chem.202102737. Epub 2021 Oct 7.
10
Anticancer gold(iii)-bisphosphine complex alters the mitochondrial electron transport chain to induce tumor inhibition.抗癌金(III)-双膦配合物改变线粒体电子传递链以诱导肿瘤抑制。
Chem Sci. 2021 Apr 29;12(21):7467-7479. doi: 10.1039/d1sc01418h.
有机铂(II)配合物的双重抗肿瘤和抗血管生成活性。
J Med Chem. 2015 Feb 12;58(3):1320-36. doi: 10.1021/jm501662b. Epub 2015 Jan 27.
4
In vivo anticancer activity of rhomboidal Pt(II) metallacycles.菱形铂(II)金属环的体内抗癌活性。
Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18448-53. doi: 10.1073/pnas.1418712111. Epub 2014 Dec 16.
5
Variability of permeability estimation from different protocols of subculture and transport experiments in cell monolayers.细胞单层中不同传代培养和转运实验方案下渗透性估计的变异性。
J Pharmacol Toxicol Methods. 2015 Jan-Feb;71:21-32. doi: 10.1016/j.vascn.2014.11.004. Epub 2014 Nov 26.
6
In vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium(II) compounds. A potential chemotherapeutic agent for triple negative breast cancer.水溶性亚氨基磷烷钌(II)化合物的体外和体内评价。一种三阴性乳腺癌的潜在化疗药物。
J Med Chem. 2014 Dec 11;57(23):9995-10012. doi: 10.1021/jm5012337. Epub 2014 Nov 26.
7
Tubulin acetylation promoting potency and absorption efficacy of deacetylase inhibitors.微管蛋白乙酰化增强去乙酰化酶抑制剂的效力和吸收效果。
Br J Pharmacol. 2015 Feb;172(3):829-40. doi: 10.1111/bph.12946. Epub 2014 Dec 15.
8
Underestimated potential of organometallic rhenium complexes as anticancer agents.有机金属铼配合物作为抗癌剂的潜在价值被低估。
ACS Chem Biol. 2014 Oct 17;9(10):2180-93. doi: 10.1021/cb500528c. Epub 2014 Aug 25.
9
Luminescent cyclometalated platinum(II) complex forms emissive intercalating adducts with double-stranded DNA and RNA: differential emissions and anticancer activities.发光的金属铂(II)配合物与双链 DNA 和 RNA 形成发光的嵌入加合物:不同的发射和抗癌活性。
Angew Chem Int Ed Engl. 2014 Sep 15;53(38):10119-23. doi: 10.1002/anie.201405384. Epub 2014 Jul 15.
10
A promising camptothecin derivative: Semisynthesis, antitumor activity and intestinal permeability.一种有前途的喜树碱衍生物:半合成、抗肿瘤活性和肠道通透性。
Eur J Med Chem. 2014 Aug 18;83:366-73. doi: 10.1016/j.ejmech.2014.06.050. Epub 2014 Jun 25.